Dianthus Therapeutics, Inc. (DNTH) delivered a return of 321.91% over the past year. Since DNTH does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Dianthus Therapeutics, Inc. one year ago would be worth $42,191 today, representing a gain of $32,191.

Dianthus Therapeutics, Inc. (DNTH) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For DNTH, the total return equals the price-only return.

Yes, Dianthus Therapeutics, Inc. (DNTH) outperformed the S&P 500 by 299.23 percentage points over the past year. DNTH delivered a total return of 321.91%, compared to the S&P 500's 22.68%. This 299.23pp alpha means investors in DNTH earned more than a passive S&P 500 index fund.

Dianthus Therapeutics, Inc. (DNTH) experienced a maximum drawdown of -19.03% over the past year, declining from its peak on 2026-04-15 to its trough on 2026-06-10. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Dianthus Therapeutics, Inc. (DNTH)'s long-term returns with dividends reinvested. Over 10 years, the total return is -67.1% (-10.5% CAGR) — $10,000 would have grown to $3,291. Over 20 years: -67.1% total return (-5.4% CAGR) — $10,000 → $3,291. Over 30 years: -67.1% total return (-3.6% CAGR) — $10,000 → $3,291. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Dianthus Therapeutics, Inc.'s best calendar year was 2019 with a total return of 152.7%. Its worst year was 2022 with a total return of -92.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 245.1 percentage points.